Barbara Gripshover is an Infectious Disease physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 72 publications with 1,677 citations (h-index 18); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Cleveland, OH 441061716
Telephone
216-844-8500Provider last certified this registry record 20 Nov 2020.
Clinical trials
- Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- La Jolla Pharmaceutical CompanyProgram year20252 payments
- Insmed, Inc.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
34.3%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor12.1%Tivicay62%Dovato16%Juluca15%Isentress7%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor11.2%Descovy53%Triumeq35%Abacavir-Lamivudine9%Emtricitabine3%Part D<11 patients+ 7 more classes in this area
Cardiovascular
28.7%Statin12.6%Atorvastatin Calcium76%Rosuvastatin Calcium22%Pravastatin Sodium3%Part D<11 patientsACE inhibitor5.5%Lisinopril81%Lisinopril-Hydrochlorothiazide19%Part D<11 patients+ 7 more classes in this area
Nervous system
10.9%SSRI4.5%Sertraline Hcl40%Paroxetine Hcl17%Citalopram Hbr17%Trazodone Hcl15%Escitalopram Oxalate12%Part D<11 patientsGabapentinoids3.1%Gabapentin76%Pregabalin24%Part D<11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Retention in HIV Care Still Matters: A Longitudinal Multisite Analysis
JAIDS Journal of Acquired Immune Deficiency Syndromes
2025 - Evaluation of an emergency department opt-out provider-driven HIV and syphilis screening and linkage-to-care program
The American Journal of Emergency Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Sophia Sundararajan, MD
University Hospitals of Cleveland
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”